A mathematical model that predicts how antibodies made by COVID-19 vaccines protect against symptomatic infections has been developed by scientists at the Indian Institute of Science (IISc), Bengaluru and the Queensland Brain Institute (QBI) in Australia.
A paper about the study was published in Nature Computational Science.